Phytoestrogens in health and illness

Indian Journal of Pharmacology

Volumn 34, Issue 5, 2002, Pages 311-320

  Rishi, R K ^a  

^a Central Drugs Laboratory India   (India)

Author keywords

Flavonoids; Malignancies; Menstrual disorders; Therapeutic potential

Indexed keywords

ANTINEOPLASTIC AGENT; COUMESTROL; COUMESTROL DERIVATIVE; DAIDZEIN; ENTERODIOL; ENTEROLACTONE; ESTROGEN; FLAVONOID; GENISTEIN; GLYCITEIN; ISOFLAVONE DERIVATIVE; LIGNAN; PHYTOESTROGEN;

ALCOHOL ABUSE; ASIA; BREAST CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DEMENTIA; DIET; DRUG BLOOD LEVEL; DRUG CLASSIFICATION; DRUG EFFECT; DRUG METABOLISM; DRUG STRUCTURE; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; EXPERIMENTAL ANIMAL; FOOD; FOOD INTAKE; HUMAN; IN VITRO STUDY; MEDICAL LITERATURE; MENSTRUAL IRREGULARITY; NONHUMAN; OSTEOPOROSIS; PROSTATE CANCER; REVIEW; RISK; SIDE EFFECT; SOCIETY;

EID: 0036799059     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (93)

1. National Academy of Sciences. Diet, nutrition, and cancer. Washington, DC; National Academy Press: 1982.
2. Arena S, Rappa C, Del Frate E, Cenci S, Villani C. A natural alternative to menopausal hormone replacement therapy. Phytoestrogens. Minerva Ginecol 2002;54:53-7.
3. Adlercreutz H. western diet and western diseases: Some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest 1990;50:210:3-23.
4. Safe SH, Pallaroni L, Yoon K, Gaido K, Ross S, Saville B, et al. Toxicology of environmental estrogens. Reprod Fertil Dev 2001;13:307-15.
5. Davis DL, Bradlow H. Can environmental estrogens cause breast cancer? Scientific American 1995;273:167-72.
6. Murkies AL, Wilcox G, Davis SR. Phytoestrogens. J Clin Endocrinol Metab 1998;83:297-303.
7. Bingham SA, Atkinson C, Liggins J, Bluck L, Coward A. Phyto-oestrogens: Where are we now? Br J Nutr 1998;79:393-406.
8. Setchell KDR. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 1998;68:1333S-46S.
9. Barnes S, Kirk M, Coward L. Isoflavones and their conjugates in soy foods: Extraction conditions and analysis by HPLC-mass spectrometry. J Agric Food Chem 1994;42:2466-74.
10. Anderson JJB, Anthony M, Messina M, Garner SC. Effects of phyto-estrogens on tissues. Nutr Res Rev 1999;12:75-116.
11. Axelson M, Sjovall J, Gustafsson B, Setchell KDR. Origin of lignans in mammals and identification of a precursor from plants. Nature 1982;298:659-60.
12. Setchell KDR. Discovery and potential clinical importance of mammalian lignans. In: Cunnane SS, Thompson LU, eds. Flaxseed in human nutrition. Champaign, IL; AOCS Press: 1995. p. 82-98.
13. Adlercreutz H, Hockerstedt K, Bannwart C. Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). J Stroid Biochem 1987;27:1135-44.
14. Hutchins AM, Lampe JW, Martini MC, Campbell DR, Slavin JL. Vegetables, fruits and legumes: Effect on urinary isoflavonoid phytoestrogen and lignan excretion. J Am Dietetic Asso 1995;95:769-74.
15. Rose DP, Boyar AP, Wynder EL. International comparisons of mortality rates for cancer of the breast, ovary, prostate and colon, and per capita food consumption. Cancer 1986;58:2363-71.
16. Morito K, Hirose T, Kinjo J, Hirakawa T, Okawa M, Nohara T, et al. Interaction of phytoestrogens with estrogen receptors alpha and beta. Biol Pharm Bull 2001;24:351-6.
17. Morito K, Aomori T, Hirose T, Kinjo J, Hasegawa J, Ogawa S, et al. Interaction of phytoestrogens with estrogen receptors alpha and beta (II). Biol Pharm Bull 2002;25:48-52.
18. Ranich T, Bhathena SJ, Velasquez MT. Protective effects of dietary phytoestrogens in chronic renal disease. J Ren Nutr 2001;11:183-93.
19. Setchell KDR. Soy isoflavones-benefits and risks from nature's selective estrogen receptor modulators (SERMs). J Am Coll Nutr 2001;20:354S-362S; discussion 381S-3S.
20. Brzezinki A. Debi A. Phytoestrogens: the "natural" selective estrogen receptor modulators. Eu J Obstet Gynecol Rep Biol 1999;85:57-61.
21. Akiyama T, Ishida J, Nakagawa S, Ogawara S, Watanabe S, Itoh N, et al. A specific inhibitor of tyrosine-specific protein kinase. J Biol Chem 1987;262:5592-5.
22. Markovits J, Linassier C, Fosse P, Courpie J, Pierre J, Jaquemin-Sablon A, et al. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res 1989;49:5111-7.
23. Peterson TG, Barnes S. Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells. Cell Growth Differentiation 1996;7:1345-51.
24. Kim H, Peterson TG, Barnes S. Mechanisms of action of the soy isoflavone genistein: Emerging role for its effects via transforming growth factor-β signaling pathways. Am J Clin Nutr 1998;68:1418S-25S.
25. Wei H, Bowen R, Cai Q, Barnes S, Wang Y. Antioxidant and antiproliferative effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med 1995;208:124-30.
26. Fotsis T, Peper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R, et al. A dietary derived inhibitor of angiogenesis. Proc Natl Acad Sci USA 1993;90:2690-4.
27. de Lemos ML. Effects of soy phytoestrogens genistein and daidzein on breast cancer growth. Ann Pharmacother 2001;35:1118-21
28. Barnes S, Grubbs C, Carlson J, Setchell KDR. Soybeans inhibit mammary tumor growth in models of breast cancer. In: Pariza MW, ed. Mutagens and carcinogens in the diet. New York: Wiley-Liss; 1990. p. 239-53.
29. Hawrylewicz EJ, Huanag HH, Blair WH. Dietary soybean isolate and methionine supplementation affect mammary tumor progression in rats. J Nutr 1991;121:1693-8.
30. Maggiolini M, Bonofiglio D, Marsico S, Panno ML, Cenni B, Picard D, et al. Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Mol Pharmacol 2001;60:595-602
31. Aldercreutz H, Fotsis T, Heikkiinen R, Dwyer JT, Woods M, Goldin BR, Gorbach SL, et al. Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian women with breast cancer. Lancet 1982;2:1295-9.
32. Aldercreutz H, Fotsis T, Lampe J, Wahala K, Makela T, Brunow G, et al. Quantitative determination of lignans and isoflavones in plasma of omnivorous and vegetarian women by isotope-dilution gas chromatography-mass spectrometry. Scand J Clin Lab Investig 1993;53:5-18.
33. Aldercreutz H, Honjo H, Higtashi A, Fotsis T, Hamalainen E, Hasegawa T, et al. Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr 1991;54:1093-100.
34. den Tonkelaar I. Keinan-Boker L, Veer PV, Arts CJ, Adlercreutz H, Thijssen JH, et al. Urinary phytoestrogens and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10:223-8.
35. Setchell KDR, Cassidy A. Dietary isoflavones: Biological effects and relevance to human health. J Nutr 1999;129:758S-67S.
36. Severson KJ, Nomura AMY, Grove JS, Stemmermann GN. A prospective study of demographics, diet and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 1989;49:1857-60.
37. Mitchell JH, Cawood E, Kinniburgh D, Provan A, Collins AR, Irvine DS, et al. Effect of a phytoestrogen food supplement on reproductive health in normal males. Clin Sci (Lond) 2001;100:613-8.
38. Messina MJ, Persky V, Setchell KDR, Barnes S. Soy intake and cancer risk: A review of the in vivo and in vitro data. Nutr Cancer 1994;21:113-31.
39. Barnes S. Effect of genistein on in vitro and in vivo models of cancer. J Nutr 1995;125:777S-83S.
40. Wang Y, Heston DWD, Fair WB. Soy isoflavones decrease the high-fat promoted growth of human prostate cancer. Results of in vivo and animal studies. J Urol 1995;153 Abstr. 161.
41. Schleicher T, Zheng M, Zhang M, Lamartiniere CA. Genistein inhibition of prostate cancer cell growth and metastasis in vivo. Am J Clin Nutr 1998;68:1526S.
42. Evans BAJ, Griffiths K, Morton MS. Inhibition of 5α-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol 1995;147:295-302.
43. Makela S, Poutanen M, Lehtimaki J, Kostian M, Santti R, Vihko R, et al. Estrogen-specific 17β-hydroxysteroid oxidoreductase type 1 (E.C. 1.1.1.62) as a possible target for the action of phytoestrogens. Proc Soc Exp Biol Med 1995;208:51-9.
44. Rosenberg Zand RS, Jenkins DJ, Brown TJ, Diamandis EP. Flavonoids can block PSA production by breast and prostate cancer cell lines. Clin Chim Acta 2002;317:17-26
45. Dewell A, Hollenbeck CB, Bruce B. The effects of soy-derived phytoestrogens on serum lipids and lipoproteins in moderately hypercholesterolemic postmenopausal women. J Clin Endocrinol Metab 2002;87:118-21
46. de Kleijn MJ, van der Schouw YT, Wilson PW, Grobbee DE, Jacques PF, de Kleijn MJ, van der Schouw YT, et al. Dietary intake of phytoestrogens is associated with a favorable metabolic cardiovascular risk profile in postmenopausal U.S. women: The Framingham study. J Nutr 2002;132:276-82
47. Ariyo AA, Villablanca AC. Estrogens and lipids. Can HRT designer estrogens, and phytoestrogens reduce cardiovascular risk markers after menopause? Postgrad Med 2002; 111:23-30.
48. Anthony MS, Clarkson TB, Hughes CL Jr, Moregan TM, Burke GL. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr 1996; 126:43-50.
49. Anthony MS, Clarkson TB, Weddle DL, Wolfe MS. Effects of soy protein phytoestrogens on cardiovascular risk factors in rhesus monkeys. J Nutr 1995; 125:803S-4S.
50. Teede HJ, Dalais FS, Kotsopoulos D, Liang YL, Davis S, McGrath BP, et al. Dietary soy has both beneficial and potentially adverse cardiovascular effects: A placebo-controlled study in men and postmenopausal women. J Clin Endocrinol Metab 2001;86:3053-60.
51. Kirk EA, Sutherland P, Wang SA, Chait A, LeBoeuf RC. Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice. J Nutr 1998; 128:954-9.
52. Vincent A, Ruan M, Fitzpatrick LA. Gender differences in the effect of genistein on vascular smooth muscle cells: A possible cardioprotective effect? J Gend Specif Med 2001;4:28-34
53. Raines EW, Ross R. Biology of atherosclerotic plaque formation: Possible role of growth factors in lesion development and the impact of soy. J Nutr 1995;125:624S-30S.
54. Sitori CR, Gianazza E, Manzoni C, Lovatti MR. Role of isoflavones in the cholesterol reduction by soy proteins in the clinic. Am J Clin Nutr 1997;65:166-71.
55. Setchell KDR. Naturally occurring non-steroidal estrogens of dietary origin. In: McLachlan JA ed. Estrogens in the environment II: Influences on development. New York: Elsevier; 1985. p. 69-85.
56. Wiseman H, O'Reilly JD, Aldercreutz H, Mallet AI, Bowey EA, Rowland IR, et al. Isoflavone phytoestrogens consumed in soy decrease F(2)-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr 2000;72:395-400.
57. Lamon-Fava S. High-density lipoproteins: Effects of alcohol, estrogen and phytoestrogens. Nutr Rev 2002;60:1-7
58. Duane W. Effects of legume consumption on serum cholesterol, biliary lipids and sterol metabolism in humans. J Lipid Res 1997;38:1120-8.
59. Wilcox JN, Blumenthal BF. Thrombotic mechanism in atherosclerosis: Potential impact of soy proteins. J Nutr 1995;125:631S-8S.
60. Price KR, Fenwick GR. Naturally occurring estrogens in foods - a review. Food Addit Contam 1985;2:73-106
61. Dempster DW, Lindsay R. Pathogenesis of osteoporosis. Lancet 1996;341:797-801.
62. Cooper C, Campion G, Melton L.J. III. Hip fractures in the elderly: A worldwide projection. Osteoporos Int 1992;2:285-9.
63. WHO Study Group Report. Assessment of fracture risk and an application to screening for postmenopausal osteoporosis. WHO Tech Rep Ser 1994;843:11-3.
64. Arjmandi BH. The role of phytoestrogens in the prevention and treatment of osteoporosis in ovarian hormone deficiency. J Am Coll Nutr 2001;20(5 Suppl):398S-402S; discussion 417S-20S.
65. Mei J, Yeung SS, Kung AW. High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 2001;86:5217-21.
66. Ho SC, Chan SG, Yi Q, Wong E, Leung PC. Soy intake and the maintenance of peak bone mass in Hong Kong Chinese women. J Bone Miner Res 2001;16:1363-9.
67. Draper CR, Edel MJ, Dick IM, Randall AG, Martin GB, Prince RL, et al. Phytoestrogens reduce bone loss and bone resorption in oophorectomized rats. J Nutr 1997;127:1795-9.
68. Arjmandi BH, Alekel L, Hollis BW, Amin D. Stacewiez-Sapuntzakis M, Gou P, et al. Dietary soy protein prevents bone loss in an ovariectomised rat model of osteoporosis. J Nutr 1996;126:161-7.
69. Fanti O, Monier-Faugere Z, Geng Z, Schmidt DJ, Morris PE, Cohen D, et al. The phytoestrogen genistein reduces bone loss in short-term ovariectomised rats. Osteoporos Int 1998;8:274-81.
70. Kuiper GGJM, Carisson B, Grandien K, Enmark E, Haggblad J, Nilsson S, et al. Comparison of the lignan binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997;138:863-70.
71. Blair HC, Jordan SE, Peterson TG, Barnes S. Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats. J Cellular Biochem 1996;61:629-37.
72. Yoshida K, Tsukamoto T, Torii H, Doi T, Naeshiro I, Uemura I, et al. Metabolism of ipriflavone (TC-80) in rats. Radioisotopes 1985;34:612-7.
73. Agnusdei D, Adami S, Cervetti R, Crepaldi G, Di Munno, Fantasia L, et al. Effects of ipriflavone on bone mass and calcium metabolism in postmenopausal osteoporosis. Bone Miner 1992;19:43S-8S.
74. Brandi ML. New treatment strategies: Ipriflavone, strontium, vitamin D metabolites and analogs. Am J Med 1993;95:69S-74S.
75. Keung WM. Biochemical studies of a new class of alcohol dehydrogenase inhibitors from Radix puerariae. Alcohol Clin Exp Res 1993;17:1254-60.
76. Xie CI, Lin RC, Antony V, Lumeng L, Li TK, Mai K, et al. Diadzin, an antioxidant isoflavonoid, decreases blood alcohol levels and shortens sleep time induced by ethanol intoxication. Alcohol Clin Exp Res 1994;18:1443-7.
77. Erkkola R. Female menopause, hormone replacement therapy and cognitive processes. Maturitas 1996;23:27S-30S.
78. Duka T, Tasker R, McGowan JF. The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females. Psychopharmacology 2000;149:129-39.
79. Jacobs DM, Tang MX, Stern Y, Sano M, Marder K, Bell KL, et al. Cognitive function in nondemented older women who took estrogen after menopause. Neurology 1998;50:368-73.
80. File SE, Jarrett N, Fluck E, Duffy R, Casey K, Wiseman H, et al. Eating soya improves human memory. Psychopharmacology (Berl) 2001;157:430-6.
81. Lephart ED, West TW, Weber KS, Rhees RW, Setchell KD, Adlercreutz H, et al. Neurobehavioral effects of dietary soy phytoestrogens. Neurotoxicol Teratol 2002;24:5-16.
82. Horn-Ross PL, Hoggatt KJ, Lee MM. Phytoestrogens and thyroid cancer risk: The san francisco bay area thyroid cancer study. Cancer Epidemiol Biomarkers Prev 2002;11:43-9.
83. Kuo SM. Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett 1996;110:41-8.
84. Rauth S, Kichina J, Green A. Inhibition of growth and induction of differentiation of metastatic melanoma cells in vitro by genistein: Chemosensitivity is regulated by cellular p53. Br J Cancer 1997;75:1559-66.
85. Velasquez MT, Bhathena SJ. Dietary phytoestrogens: A possible role in renal disease protection. Am J Kidney Dis 2001;37:1056-68.
86. Cassidy A, Bingham S, Setchell KDR. Biological effects of isoflavones in young women: Importance of the chemical composition of soybean products. Br J Nutr 1995;74:587-601.
87. Wu AH, Ziegler RG, Homross PL, Nomura AMY, West DW, Kolonel LN, et al. Tofu and risk of breast cancer in Asian-Americans. Cancer Epidemiol Biomark Prev 1996;5:901-6.
88. Treolar AE, Boynton RE, Behn BG, Brown BW. Variation of the human menstrual cycle through reproductive life. Int J Fertil 1970;12:77-126.
89. Henderson BE, Ross RK, Judd HL, Frailo MD, Pike MC. Do regulatory ovulatory cycles increase breast cancer risk? Cancer 1985;56:1206-8.
90. Cassidy A, Bingham S, Setchell KDR. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 1994;60:333-40.
91. Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forini E, DeAloysio D, et al. The effects of dietary soy supplementation on hot flushes. Obstet Gynecol 1998;91:6-11.
92. Brzezinski A, Adlercreutz H, Shaoul R, Rosler A, Shmueli A, Tanos V, et al. Short-term effects of phytoestrogen-rich diet on postmenopausal women. Menopause 1997;4:89-94.
93. Wilcox G, Wahlqvist ML, Burger HG, Medley G. Oestrogen effects of plant derived foods in postmenopausal women. Br Med J 1990;301:905-6.